Tvardi Therapeutics, Inc. (TVRD): Depreciation & Amortization
$95.0K
Year ended 2025-12-31
$95.0K
Trailing 12 months to 2026-06-30
-27.4%
3-year compound annual growth
-14.6%
5-year compound annual growth
-19.6%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $95.0K | 0.0% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $95.0K | -63.3% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $259.0K | +4.4% | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | $248.0K | 0.0% | 2025-03-11, From 2022-01-01 |
| 2021-12-31 | $248.0K | +18.7% | 2024-03-06, From 2021-01-01 |
| 2020-12-31 | $209.0K | +5.6% | 2023-03-06, From 2020-01-01 |
| 2019-12-31 | $198.0K | -46.5% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $370.0K | -25.3% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $495.0K | -66.2% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $1.47M | +74.6% | 2019-03-12, From 2016-01-01 |
| 2015-12-31 | $839.0K | +7.2% | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | $783.0K | -0.8% | 2017-03-10, From 2014-01-01 |
| 2013-12-31 | $789.0K | -22.7% | 2016-03-11, From 2013-01-01 |
| 2012-12-31 | $1.02M | n/a | 2015-03-27, From 2012-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | 2025-12-31 | $95.0K | 0.0% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $1.63M | n/m |
| Valion Bio, Inc. (VBIO) | 2024-12-31 | $3.0K | -62.5% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $1.50M | -42.6% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $23.0K | +475.0% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $332.1K | +48.6% |
| Sol-Gel Technologies Ltd. (SLGL) | 2025-12-31 | $109.0K | -53.2% |
| Veru Inc. (VERU) | 2025-09-30 | $152.1K | -43.3% |
| Talphera, Inc. (TLPH) | 2024-12-31 | $0 | -100.0% |
Compare TVRD, DARE, VBIO, CPHI side by side · Screen every company in Pharmaceutical Preparations ↗